Treatment of Non-Gestational Acute Uterine Bleeding: A Randomized Trial
Completed · Not applicable
Conditions studied: Uterine Hemorrhage, Menorrhagia
In brief
To determine the relative efficacy of multidose medroxyprogesterone acetate (MPA, Provera) and a multidose, monophasic combination oral contraceptive in the treatment of hemodynamically stable women with non-gestational, acute uterine bleeding.
Key facts
- Study ID
- NCT00350480
- Run by
- Kaiser Permanente
- People needed
- 240
- Starts
- 2003-04-01
- Expected to finish
- 2005-06-01
- Last updated by the study team
- 2015-03-11
Who can join
Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Non-pregnant Hemodynamically stable Reproductive-aged women >18 years Present with acute uterine bleeding
You may not qualify if…
- Pregnant Non-hemodynamically stable <18 years
Where it is running
- Kaiser Permanente Sunset — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.